Regenerative Biologics for Wellness and Longevity

IV Wellness | Anti-Aging | Longevity Protocols | Functional Medicine

The Regenerative Biologic Platform The Longevity Market Has Been Waiting For.

Clinical-grade 25M UCT-MSC vials and 3D-cultured exosome biologics for wellness centers, longevity clinics, IV therapy practices, and functional medicine providers. Address the biology of aging at the cellular level — inflammaging, cellular senescence, immune dysregulation, and mitochondrial decline. USA-made, cGMP-aligned, FDA Type II Drug Master File registered.

Enroll Your Practice CLICK HERE | Book a Consultation CLICK HERE

NTA-Verified | FDA Type II DMF | 97% Post-Thaw Viability | Immune-Privileged | USA-Made

Why Longevity & Wellness Practices Are Adding Regenerative Biologics

The longevity medicine market is shifting from symptom management to root-cause biology. Patients coming to functional medicine, IV therapy, and wellness clinics are increasingly sophisticated — they are asking about "inflammaging," cellular senescence, and systemic immune modulation. Peptides, NAD+, and IV nutrition are table stakes in this market now. UCT-MSC biologics are the next tier.

The scientific rationale is compelling: chronic low-grade inflammation — the "inflammaging" phenomenon — is now recognized as the central driver of accelerated biological aging. MSC-derived biologics address this directly through immunomodulatory paracrine signaling, not through pharmaceutical suppression.

Next Tier Beyond Peptides

Peptides and NAD+ are now standard longevity offerings. UCT-MSC biologics position your practice at the frontier — offering what elite biohacking and longevity clinics are adopting first.

Addresses Inflammaging Directly

MSC biologics target the chronic low-grade systemic inflammation driving accelerated biological aging — through macrophage polarization, NF-κB suppression, and Treg modulation.

High-Value Subscription Revenue

Wellness IV exosome protocols generate $795–$1,495 per session with subscription models driving $19,900–$31,800/month from 20–30 active members alone.

Stacks with Existing Protocols

UCT-MSC biologics integrate naturally alongside NAD+, peptides, glutathione, and other IV wellness protocols — expanding the session value without replacing what works.

Next Tier Beyond Peptides

Chronic low-grade systemic inflammation — "inflammaging" — is driven by persistent NF-κB pathway activation and declining immune regulation. UCT-MSC exosomes carry microRNAs that suppress NF-κB expression and promote M1→M2 macrophage polarization, directly reducing the inflammatory burden driving accelerated aging.

Immune Regulation & Treg Support

Immune dysregulation — declining Treg populations and rising Th17 activity — is a hallmark of aging. MSC-derived exosomes increase regulatory T-cell populations and their products, helping restore the immune balance that deteriorates with age and drives both autoimmune tendencies and chronic inflammation.

Paracrine Repair Activation

MSCs secrete cytokines, signaling molecules, and growth factors that activate endogenous stem cells to perform tissue repair after damage (Gnecchi et al., 2016). This paracrine mechanism — signaling the body's own repair machinery — is the primary reason UCT-MSC biologics are relevant to systemic wellness and longevity protocols.

MicroRNA Gene Expression Recalibration

UCT-MSC exosomes contain over 800 unique microRNAs that influence gene expression across multiple biological pathways simultaneously. MSC-derived EVs play obvious therapeutic roles in diseases of tissue damage or inflammation, with broad implications for aging-related biological decline (Wei et al., Frontiers in Pharmacology, 2021).

The highest-tier biologic for systemic longevity and cellular renewal protocols. Live human umbilical cord tissue-derived MSCs from a perinatal source — biologically young, never lyophilized, with verified viability and purity on every lot. The primary product for practices offering premium UCT-MSC protocols.

97% post-thaw viability (COA-verified) · 100% CD90 and CD166 · Never lyophilized
Systemic immunomodulation · Inflammaging reduction · Paracrine repair activation
Immune-privileged — low rejection risk due to UCT-MSC immunological profile
Xeno-Free · FBS-Free · FDA Type II Drug Master File · AATB-Accredited US facility

Most exosomes on the market are freeze-dried or made using outdated 2D cultures-leading to degraded or inconsistent products.

Our exosomes are:

Fresh (not lyophilized)
3D-cultured for up to 20x more signaling molecules
Backed by an FDA Master File for transparency and traceability

Clinics report faster recovery and better results with fewer sessions.

Every batch is tested both independently and in house for purity, sterility, identity, and potency.

Regulatory Transparency

Registered with an FDA Master File, we offer clear documentation and clinical-grade confidence.

We use MSCs from Wharton’s Jelly—highly potent and low in immunogenicity, offering richer regenerative factors than cord blood or other sources.

Our 3D bioreactor systems mimic in vivo conditions, enhancing cell function and boosting exosome output.

No animal components. Just clean, consistent, clinical-grade expansion with reduced immune risks.

Our exosomes are never freeze-dried, preserving their structure and full bioactivity for stronger results.